Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07248865
PHASE1

A Phase 1 Study of CLYM116 in Normal Healthy Volunteers

Sponsor: Climb Bio, Inc.

View on ClinicalTrials.gov

Summary

This Phase 1, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CLYM116 in healthy volunteers.

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose (SAD) and Multiple-Ascending-Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Injection(s) of CLYM116 in Normal Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-12-02

Completion Date

2026-09

Last Updated

2026-02-20

Healthy Volunteers

Yes

Interventions

DRUG

CLYM116

CLYM116 to be administered by SC injection

DRUG

Placebo

Placebo solution to be administered at a matching volume by SC injection

Locations (1)

Nucleus Network Brisbane

Brisbane, Australia